Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 55.0K | -- | 0.59% | +32.8K | 2026-06-30 |
| Davidson Kahn Capital Management, LLC | 25.0K | -- | 0.27% | -- | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 23.4K | -- | 0.25% | +1.5K | 2026-06-30 |
| BlackRock, Inc. | 9.6K | -- | 0.10% | +2.8K | 2026-06-30 |
| VANGUARD FIDUCIARY TRUST CO | 9.4K | -- | 0.10% | -- | 2026-06-30 |
| MORGAN STANLEY | 1.3K | -- | 0.01% | -- | 2026-06-30 |
| Tower Research Capital LLC (TRC) | 349 | -- | 0.00% | -968 | 2026-06-30 |
| MERCER GLOBAL ADVISORS INC /ADV | 250 | -- | 0.00% | -- | 2026-06-30 |
| UBS Group AG | 203 | -- | 0.00% | +179 | 2026-06-30 |
